These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2127830

  • 1. Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers.
    Aarseth HP, Ganss R.
    Nephrol Dial Transplant; 1990; 5(11):942-4. PubMed ID: 2127830
    [Abstract] [Full Text] [Related]

  • 2. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis.
    Chang TM, Barre P.
    Lancet; 1983 Nov 05; 2(8358):1051-3. PubMed ID: 6138600
    [Abstract] [Full Text] [Related]

  • 3. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers.
    Gabutti L, Taminelli-Beltraminelli L, Marone C.
    Eur J Clin Pharmacol; 1997 Nov 05; 53(2):123-6. PubMed ID: 9403283
    [Abstract] [Full Text] [Related]

  • 4. Aluminium kinetics during haemodialysis with the Redy 2000 Sorbsystem.
    Curtis JR, Sampson B.
    Int J Artif Organs; 1989 Nov 05; 12(11):683-7. PubMed ID: 2599666
    [Abstract] [Full Text] [Related]

  • 5. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
    Weiss LG, Danielson BG, Fellström B, Wikström B.
    Nephron; 1989 Nov 05; 51(3):325-9. PubMed ID: 2918944
    [Abstract] [Full Text] [Related]

  • 6. Haemofiltration or haemodialysis in aluminium elimination?
    Sulkova S, Laurincova Z, Válek A.
    Nephrol Dial Transplant; 1991 Nov 05; 6 Suppl 3():3-5. PubMed ID: 1775263
    [Abstract] [Full Text] [Related]

  • 7. Desferrioxamine induced aluminium removal in haemodialysis.
    Bonal J, Montoliu J, Löpez Pedret J, Bergadä E, Andrew L, Bachs M, Revert L.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Nov 05; 21():366-70. PubMed ID: 3991524
    [Abstract] [Full Text] [Related]

  • 8. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981 Nov 05; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
    Sulková S, Laurincová Z, Pancírová J, Komonová D, Válek A.
    Cas Lek Cesk; 1990 Aug 10; 129(32):998-1001. PubMed ID: 2208242
    [Abstract] [Full Text] [Related]

  • 10. Clearance of aluminium desferrioxamine by haemodialysis using a polysulfone high flux membrane.
    Day JP, Hewitt CD, Ackrill P, Hill K.
    Contrib Nephrol; 1989 Aug 10; 74():101-5. PubMed ID: 2702125
    [No Abstract] [Full Text] [Related]

  • 11. Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidism.
    Tsuruoka S, Yamamoto H, Ioka T, Ando H, Saito T, Fujimura A.
    Br J Clin Pharmacol; 2004 Nov 10; 58(5):488-95. PubMed ID: 15521896
    [Abstract] [Full Text] [Related]

  • 12. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

  • 13. Deferoxamine and aluminum clearance in pediatric hemodialysis patients.
    Ogborn MR, Dorcas VC, Crocker JF.
    Pediatr Nephrol; 1991 Jan 15; 5(1):62-4. PubMed ID: 2025542
    [Abstract] [Full Text] [Related]

  • 14. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
    Delmez J, Weerts C, Lewis-Finch J, Windus D, Slatopolsky E.
    Am J Kidney Dis; 1989 Apr 15; 13(4):308-11. PubMed ID: 2705449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.
    Ciancioni C, Poignet JL, Naret C, Delons S, Mauras Y, Allain P, Man NK.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Apr 15; 21():469-73. PubMed ID: 3991542
    [Abstract] [Full Text] [Related]

  • 18. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG, Acuña Aguerre G, Fernández Martín JL, Mouzo R, Cannata Andía JB.
    Nephrol Dial Transplant; 1994 Apr 15; 9(10):1431-4. PubMed ID: 7816256
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
    Allain P, Chaleil D, Mauras Y, Beaudeau G, Varin MC, Poignet JL, Ciancioni C, Ang KS, Cam G, Simon P.
    Clin Chim Acta; 1987 Dec 15; 170(2-3):331-8. PubMed ID: 3436066
    [Abstract] [Full Text] [Related]

  • 20. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
    Mourad A, Carney S, Gillies A, Jones B, Nanra R, Trevillian P.
    Nephrol Dial Transplant; 2004 Nov 15; 19(11):2797-802. PubMed ID: 15340092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.